Lb 2102 News Today

Legend Biotech Corp. is entering what it no doubt hopes will be another fruitful collaboration with big pharma. Legend’s wholly owned subsidiary, Legend Biotech Ireland Ltd., will work with Novartis AG in an exclusive global development and license agreement for chimeric antigen receptor T-cell therapies targeting DLL3.

A divided Senate voted June 8 to require that anyone arrested for any felony provide a DNA sample to police, whether or not they ever are charged or not, much